XML 16 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenue:        
Revenue $ 85,821 $ 105,789 $ 159,126 $ 211,419
Cost of revenue:        
Cost of revenue 47,087 62,266 89,540 122,070
Gross profit 38,734 43,523 69,586 89,349
Operating expenses:        
Research and development 10,233 9,350 24,723 17,733
Sales and marketing 13,153 14,824 21,825 30,680
General and administrative 10,263 14,329 20,395 32,905
Restructuring charges 1,585 821 2,637 1,084
Total operating expenses 35,234 39,324 69,580 82,402
Income from operations 3,500 4,199 6 6,947
Other income (expense), net (312) 76 (697) 165
Interest expense (7,578) (6,347) (14,015) (12,653)
Net loss before income taxes (4,390) (2,072) (14,706) (5,541)
Income tax provision 202 243 622 581
Net loss $ (4,592) $ (2,315) $ (15,328) $ (6,122)
Net loss per share - basic and diluted (in dollars per share) $ (0.11) $ (0.06) $ (0.38) $ (0.17)
Weighted average shares - basic and diluted (in shares) 40,286 36,297 40,097 36,172
Foreign currency translation adjustments, net $ 722 $ (474) $ 1,009 $ (390)
Total comprehensive loss (3,870) (2,789) (14,319) (6,512)
Product        
Revenue:        
Revenue 50,850 68,130 90,537 133,926
Cost of revenue:        
Cost of revenue 34,998 49,467 65,380 96,666
Service        
Revenue:        
Revenue 31,494 32,401 61,880 65,781
Cost of revenue:        
Cost of revenue 12,089 12,799 24,160 25,404
Royalty        
Revenue:        
Revenue $ 3,477 $ 5,258 $ 6,709 $ 11,712